Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Labelled Comp Radiopharm. 2013 Nov 13;57(1):25–35. doi: 10.1002/jlcr.3134

Figure 6.

Figure 6

Chelate (desferrioxamine (DFO)) to mAb (panitumumab) molar labeling ratio was measured at various chelates to mAb mixing ratios. Reaction was repeated three times for each data point.